Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results
Saad Z. Usmani, Maria Victoria Mateos, Vania Hungria, Shinsuke Iida, Nizar J. Bahlis, Hareth Nahi, Hila Magen, Michele Cavo, Cyrille Hulin, Darrell White, Valerio De Stefano, John Fastenau, Mary Slavcev, Christoph Heuck, Xiang Qin, Huiling Pei, Tara Masterson, Kristen Lantz, Katharine S. Gries
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results'. Together they form a unique fingerprint.